LobbyingAmerican Society for Dermatologic Surgery Association lobbying by quarter
American Society for Dermatologic Surgery Association's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.
American Society for Dermatologic Surgery Association
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $0 | 1 |
| Q1 2023 | $0 | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$0 · 14 reports
- Health issues$0 · 11 reports
- Budget and appropriations$0 · 2 reports
- Veterans$0 · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES13 reports
- SENATE11 reports
- Centers For Medicare and Medicaid Services (CMS)10 reports
- Food & Drug Administration (FDA)6 reports
- Health & Human Services, Dept of (HHS)3 reports
- Veterans Affairs, Dept of (VA)2 reports
- Agency for Healthcare Research & Quality (AHRQ)1 reports
- Justice, Dept of (DOJ)1 reports
- Labor, Dept of (DOL)1 reports
- Medicare Payment Advisory Commission (MedPAC)1 reports
- Office of Management & Budget (OMB)1 reports
- Treasury, Dept of1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAmerican Society for Dermatologic Surgery Association | $0 | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/22for Q2 | In-house | Under $5,000 |
| 04/10for Q1 | In-house | Under $5,000 |
| 01/13for Q4 2025 | In-house | Under $5,000 |
| 25/11/06for Q3 2025 | In-house | Under $5,000 |
| 25/07/10for Q2 2025 | In-house | Under $5,000 |
| 25/05/05for Q1 2025 | In-house | Under $5,000 |
| 25/01/10for Q4 2024 | In-house | Under $5,000 |
| 24/11/07for Q3 2024 | In-house | Under $5,000 |
| 24/07/15for Q2 2024 | In-house | Under $5,000 |
| 24/04/18for Q1 2024 | In-house | Under $5,000 |
| 24/04/18for Q1 2024 | In-house | Under $5,000 |
| 24/01/10for Q4 2023 | In-house | Under $5,000 |
| 23/10/10for Q3 2023 | In-house | Under $5,000 |
| 23/07/18for Q2 2023 | In-house | Under $5,000 |
| 23/07/17for Q2 2023 | In-house | Under $5,000 |
| 23/04/20for Q1 2023 | In-house | Under $5,000 |
| 23/01/20for Q4 2022 | In-house | Under $5,000 |